Acute Upper Respiratory Tract Infection

Respiratory
0
Pipeline Programs
1
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Drug Modality Breakdown

Cell Therapy
2100%

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Plus Therapeutics
2 programs
KagocelN/ACell Therapy1 trial
KagocelN/ACell Therapy1 trial
Active Trials
NCT04611061CompletedEst. Jun 2018
NCT04626622CompletedEst. Jun 2018

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Plus TherapeuticsKagocel
Plus TherapeuticsKagocel

Clinical Trials (2)

Kagocel® for the Prevention of ARVI and Influenza in Young People

Start: Feb 2018Est. completion: Jun 2018
N/ACompleted

Kagocel® for the Prevention of ARVI and Influenza in Adults Health Care Workers

Start: Oct 2017Est. completion: Jun 2018
N/ACompleted

Related Jobs in Respiratory

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space